Skip to content

Public FDA record

Z-0574-06: Roche brand CEDIA Tobramycin II Reagent, Catalog # 1815385, Material # 11815385216.

Recall record Z-0574-06 for Roche Diagnostics Corp.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0574-06
Company in FDA record
Roche Diagnostics Corp.
FDA classification date
Feb 28, 2006
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 20, 2026
Recall classification
Unknown — no matched enforcement classification

Reason stated in the source

May have tobramycin over-recovery at the trough level.

Source facts

Action
Consignees were notified via phone and faxed recall letter on or about 2/10/06.
Initiated
2006-02-10
Root cause
Other
Terminated
2006-06-23
Distribution
Nationwide.
Recall number
Z-0574-06
Recall status
Terminated
CDRH record ID
44150
FDA classified
2006-02-28
Recall event number
34590

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗